Get startedLog in
    Picture of Annexin Pharmaceuticals AB (publ) logo

    ANNX — Annexin Pharmaceuticals AB (publ) News Story

    0.000.00%
    se flag iconLast trade - 00:00
    HealthcareHighly SpeculativeMicro CapSucker Stock
    All News

    Brief: Annexin Pharmaceuticals: Publication Points To Possibility Of Treating COVID-19 With ANXV

    Picture of Annexin Pharmaceuticals AB (publ) logoAnnexin Pharmaceuticals AB (publ)
    01/10/2020 13:11
    Oct 1 (Reuters) - Annexin Pharmaceuticals AB (publ)
 ANNX.ST :
    * PUBLICATION POINTS TO POSSIBILITY OF TREATING COVID-19
WITH ANXV
    * WILL EXPLORE OPPORTUNITIES FOR SEPARATE FINANCING OF STUDY
WITHIN COVID-19, WITHOUT COMPROMISING RESOURCES FOR PHASE 1
STUDY IN HEALTHY VOLUNTARY OR IMAGING STUDY

Source text for Eikon:  ID:nWkrbHW9CG 
Further company coverage:  ANNX.ST 

 (Gdansk Newsroom)
 ((gdansk.newsroom@thomsonreuters.com; +48 58 778 51 10;))

    Recent news on Annexin Pharmaceuticals AB (publ)

    See all news